Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...

A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...

This article is all about what’s new and what it might mean for us, covering the latest in genetics in news. New methods like ...

A recent study in the journal PNAS from the lab of Julie Overbaugh reveals a previously unknown antiviral function of a gene ...

Data presented at ASH suggest that the CRISPR therapy could provide a one-time functional cure in children as young as 5 ...

In cooperation with universities, the Center of Estonian Rural Research and Knowledge (METK) is leading a project aimed at ...

Penn Medicine shows how sustained research investment drives innovation, economic growth, and global health breakthroughs.

Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an ...

Crispr Therapeutics AG ( ($CRSP) ) has risen by 9.03%. Read on to learn why. Crispr Therapeutics AG has seen its stock price rise by 9.03% over ...